GLP-1 Black Friday deals, verified on each provider’s own page
GLP-1 medications are among the most effective tools available for lowering A1C — and for many people with type 2 diabetes, the results go well beyond what older diabetes medications typically achieved.
How they work on blood sugar:
What kind of A1C improvement is realistic:
Meaningful reductions are common, particularly for people starting with elevated A1C. Some people see dramatic drops — moving from well into diabetic range to pre-diabetic or even normal range over the course of a year. Results vary based on starting A1C, dose, how long you've had diabetes, and lifestyle factors.
Ozempic vs. Mounjaro/Tirzepatide:
Tirzepatide (Mounjaro) targets both GLP-1 and GIP receptors, and tends to show stronger glycemic and weight outcomes than single-agonist options for many people — though individual response varies, and some do better switching medications than increasing doses.
Sustaining the gains:
A1C improvements are generally tied to staying on the medication. Some people maintain improvements after stopping if they've built lasting dietary habits, but this isn't guaranteed.
If glycemic control is a primary goal, talk to your provider about which medication and dose makes the most sense for your starting numbers.
Different ways people phrase this question. Each expands to the same answer.
GLP-1 medications are among the most effective tools available for lowering A1C — and for many people with type 2 diabetes, the results go well beyond what older diabetes medications typically achieved.
How they work on blood sugar:
What kind of A1C improvement is realistic:
Meaningful reductions are common, particularly for people starting with elevated A1C. Some people see dramatic drops — moving from well into diabetic range to pre-diabetic or even normal range over the course of a year. Results vary based on starting A1C, dose, how long you've had diabetes, and lifestyle factors.
Ozempic vs. Mounjaro/Tirzepatide:
Tirzepatide (Mounjaro) targets both GLP-1 and GIP receptors, and tends to show stronger glycemic and weight outcomes than single-agonist options for many people — though individual response varies, and some do better switching medications than increasing doses.
Sustaining the gains:
A1C improvements are generally tied to staying on the medication. Some people maintain improvements after stopping if they've built lasting dietary habits, but this isn't guaranteed.
If glycemic control is a primary goal, talk to your provider about which medication and dose makes the most sense for your starting numbers.
GLP-1 medications are among the most effective tools available for lowering A1C — and for many people with type 2 diabetes, the results go well beyond what older diabetes medications typically achieved.
How they work on blood sugar:
What kind of A1C improvement is realistic:
Meaningful reductions are common, particularly for people starting with elevated A1C. Some people see dramatic drops — moving from well into diabetic range to pre-diabetic or even normal range over the course of a year. Results vary based on starting A1C, dose, how long you've had diabetes, and lifestyle factors.
Ozempic vs. Mounjaro/Tirzepatide:
Tirzepatide (Mounjaro) targets both GLP-1 and GIP receptors, and tends to show stronger glycemic and weight outcomes than single-agonist options for many people — though individual response varies, and some do better switching medications than increasing doses.
Sustaining the gains:
A1C improvements are generally tied to staying on the medication. Some people maintain improvements after stopping if they've built lasting dietary habits, but this isn't guaranteed.
If glycemic control is a primary goal, talk to your provider about which medication and dose makes the most sense for your starting numbers.
Listed by price only, as each provider shows it on its own site; check your state and any extra fees there. Compounded medications are not FDA-approved. AllGLP1 may earn a commission when you visit a provider. Every verified price
Paying for a GLP-1 yourself? Lowest month-to-month prices we re-read today for compounded injections: Tirzepatide from $118/mo, Semaglutide from $79/mo. Get an email before you renew if another provider is cheaper
GLP-1 medications are among the most effective tools available for lowering A1C — and for many people with type 2 diabetes, the results go well beyond what older diabetes medications typically achieved.
How they work on blood sugar:
What kind of A1C improvement is realistic:
Meaningful reductions are common, particularly for people starting with elevated A1C. Some people see dramatic drops — moving from well into diabetic range to pre-diabetic or even normal range over the course of a year. Results vary based on starting A1C, dose, how long you've had diabetes, and lifestyle factors.
Ozempic vs. Mounjaro/Tirzepatide:
Tirzepatide (Mounjaro) targets both GLP-1 and GIP receptors, and tends to show stronger glycemic and weight outcomes than single-agonist options for many people — though individual response varies, and some do better switching medications than increasing doses.
Sustaining the gains:
A1C improvements are generally tied to staying on the medication. Some people maintain improvements after stopping if they've built lasting dietary habits, but this isn't guaranteed.
If glycemic control is a primary goal, talk to your provider about which medication and dose makes the most sense for your starting numbers.